top of page

Tvashtr Biotech

We are Tvashtr Biotech Private Limited, an India-based Biotech start-up focusing on bridging the gap from eliminating laboratory dependency to developing novel, rapid, portable, easy-to-use and scalable technologies.

Worried child
Injecting Epinephrine
Allergic Reaction

Gaps in Allergy Diagnosis

With over 400 million people suffering from allergies globally, yet 70% of them undiagnosed, we’re here to change that!

Recurring High Costs

Traditional tests are costly ($300–$1,000) in a $1.3B industry

Lack of adaptable technologies!

The unavailability of lab-accurate easy-to-use, rapid and portable devices.

Time-consuming Process

Requires specialized lab infrastructure, and takes several days to process and deliver results

Inconvenience to users

Methods such as skin-prick testing and patch-based testing used often cause a lot of discomfort to the user

​But can this all be done at your convenience anywhere, with lab-grade accuracy, without the doctor's interference, and with the consultation of post-test support. You should be able to take this decision into your own hands, right?

Prevalence of Food Allergies in USA

  1. At least 26 million adults have food allergies, according to a 2019 joint study funded in part by the National Institute of Allergy and Infectious Disease. (Link)
     

  2. 45.3% of those with food allergies are allergic to multiple foods. (Link)
     

  3. 42.3% of children with food allergies have experienced a severe reaction. (Link)​
     

  4. 19% of children with food allergies report an emergency department visit due to food allergies in the previous year (42% report at last one previous emergency department visit due to food allergies) (Link)
     

  5. Childhood food allergies alone cost the United States $24.8 billion annually. (Link)

    1. ​The per child cost is $4,184​​

    2. Direct medical costs are $4.3 billion 

    3. ​Costs that families are responsible for totaled $20.5 billion, which includes doctor and emergency department visits, hospitalizations, out-of-pocket expenses, loss of job productivity, and specialty foods

​

Tvashtr Biotech Private Limited Change is the Only Constant (1).png

IMPACT!

US Market

50M+

People Affected with Food Allergies annually

47%

affected adults and children with multiple Food allergies

$1.3Bn

Market Size(TAM)

9.2% CAGR

$30Bn+

Spent annually for Food Allergy diagnosis

Lifestyle of Allergy Patients

Constant Fear

The constant fear for people with food allergies is the risk of accidental exposure leading to a severe or life-threatening allergic reaction (anaphylaxis). 

  • Delayed or inadequate medical response

  • Social and lifestyle limitations

Frequent Visits

Why now?

Patients need routine visits for epinephrine auto-injectors, antihistamines, and personalized emergency action plans. Regular checkups help track allergy severity, assess immune responses, and update dietary restrictions.

Post-COVID, a sudden shift toward home-based, rapid diagnostics has encouraged diagnosis at the user's comfort and the potential to develop diagnostic tools in a newly penetrable market segment.

Our Approach

WE are approaching the problems by developing the following  solutions!

01

Rapid & Portable

The current need for market adoption is for a device that does not require any laboratory dependency and can provide rapid results.

02

Easy-to-Use

The complete automation of processes for lab-accurate results, and zero-intervention and requirement of medical professional supervision.

03

Post-test Support

Interpretation of results, with integrative AI for lifestyle support to help with food habits, body fitness and enabling direct control over health for users.

04

Whole-Body Wellness

Our approach blends diagnosis and lifestyle support to improve overall health and day-to-day life.

Rapid Allergy Testing Kit

Our Proposed Solution:

value proposition.png
image__1_-removebg-preview.png

Fully Autonomous, safely disposable, and electronics-free device.

tasso_device_edit-removebg-preview.png

Our Partners

SISFS Investor
Also incubated at
Research Partner
Academia Partner
BGIIES_image-removebg-preview.png
logo-1 (1).png
bottom of page